Management of vascular access puncture site after percutaneous transluminal angioplasty using calcium alginate sheet

Management of vascular access puncture site after percutaneous transluminal angioplasty using calcium alginate sheet - Comparative examination of hemostatic sheet after percutaneous transluminal angioplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027022

Enrollment

250

Registered

2017-04-17

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular access failure

Interventions

We use the calcium alginate sheet to achieve hemostasis. We use the non-drug sheet to achieve hemostasis.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients of 250 cases who undergo PTA in Tsuchiya General Hospital from November 1, 2016.

Exclusion criteria

Exclusion criteria: Patients who did not consent to this study, were punctured with respect to arteries, were used more than three sheaths, and had hematoma at the puncture site during PTA.

Design outcomes

Primary

Measure	Time frame
The rate of "time to hemostatsis" (5, 10, 15, and >15 minutes) at the puncture sites after PTA in each group.	—

Secondary

Measure	Time frame
Safety (confirmation of complications)	—

Countries

Japan

Contacts

Public ContactMakoto Matsubara

Tsuchiya General Hospital Department of artificial organs

white_jack0070@yahoo.co.jp082-243-9191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026